Owner Meiji Seika Pharma Co., Ltd.

Inventors Anzai, Hiroyuki; Yamamoto, Kentaro; Oyama, Kazuhiko; Tsuchida, Mariko; Goto, Kimihiko; Mitomi, Masaaki

Agent Davies Collison Cave

Pub. Number AU-A-2011210967

PCT Pub. Number WO2011/093185

Priority 2010-014727 26.01.10 JP

Filing date 19 January 2011

Wipo publication date 4 August 2011

C12P 17/18 Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

C12N 1/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology